Sommaire

• • ·Table of Contents

    Page :A3

    
• • ·Editorial Board

    Page :A8

    
• • ·Information for Authors

    Page :A9

    
• • ·Information for Authors

    Page :A10

    
• • ·Information for Readers

    Page :A11

    

• Editorial

  • ·Biomarker screening for cardiac dysfunction: The more the merrier?

    Page :1-3

    W.H. Wilson Tang

    

• Curriculum in Cardiology

  • ·Current status of the total artificial heart

    Page :4-10

    Norman A. Gray, Craig H. Selzman

    Résumé Résumé Plan Plan  
  • ·The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: Current status in an era of revascularization and reperfusion

    Page :11-18

    Mircea Petrina, Shaun G. Goodman, Kim A. Eagle

    Résumé Résumé Plan Plan  
  • ·Heparin-induced thrombocytopenia and cardiovascular diseases

    Page :19-26

    Pranab Das, Khaled Ziada, Steven R. Steinhubl, David J. Moliterno, Hussam Hamdalla, Joseph Jozic, Debabrata Mukherjee

    Plan Plan  
  • ·Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

    Page :27-38

    Christoph Stettler, Sabin Allemann, Peter Jüni, Carole A. Cull, Rury R. Holman, Matthias Egger, Stephan Krähenbühl, Peter Diem

    Résumé Résumé Plan Plan  
  • ·Statin use in heart failure: A cause for concern?

    Page :39-49

    Amresh Raina, Thomas Pickering, Daichi Shimbo

    Résumé Résumé Plan Plan  

• Results of Expert Meetings

  • ·Evaluation of diagnostic imaging technologies and therapeutics devices: Better information for better decisions : Proceedings of a multidisciplinary workshop

    Page :50-58

    Robert M. Califf, for the Workshop Participants

    Résumé Résumé Plan Plan

• Trial Design

  • ·Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial

    Page :59-66

    Christopher J. Cooper, Timothy P. Murphy, Alan Matsumoto, Michael Steffes, David J. Cohen, Michael Jaff, Richard Kuntz, Kenneth Jamerson, Diane Reid, Kenneth Rosenfield, John Rundback, Ralph D' Agostino, William Henrich, Lance Dworkin

    Résumé Résumé Plan Plan  
  • ·Intravascular ultrasound assessment of novel antiatherosclerotic therapies: Rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study

    Page :67-74

    Stephen J. Nicholls, Ilke Sipahi, Paul Schoenhagen, Lisa Wisniewski, Tammy Churchill, Timothy Crowe, Marlene Goormastic, Kathy Wolski, E. Murat Tuzcu, Steven E. Nissen, for the ACTIVATE Investigators

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Clinical, imaging, and pathological characteristics of left ventricular thrombus: A comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation

    Page :75-84

    Monvadi B. Srichai, Chelif Junor, L. Leonardo Rodriguez, Arthur E. Stillman, Richard A. Grimm, Michael L. Lieber, Joan A. Weaver, Nicholas G. Smedira, Richard D. White

    Résumé Résumé Plan Plan  
  • ·Effect of teaching and type of stethoscope on cardiac auscultatory performance

    Page :85.e1

    Kasper Iversen, Ane Søgaard Teisner, Morten Dalsgaard, Rasmus Greibe, Hans Bording Timm, Lene Theil Skovgaard, Asbjørn Hróbjartsson, Ø. Copenhagen, S. Copenhagen, K. Copenhagen

    Résumé Résumé Plan Plan
  • ·Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

    Page :86-92

    Anique Ducharme, Karl Swedberg, Marc A. Pfeffer, Alain Cohen-Solal, Christopher B. Granger, Aldo P. Maggioni, Eric L. Michelson, John J.V. McMurray, Lars Olsson, Jean L. Rouleau, James B. Young, Bertil Olofsson, Margareta Puu, Salim Yusuf, on behalf of the CHARM Investigators k

    Résumé Résumé Plan Plan  
  • ·Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy

    Page :93.e1

    Stefano Bonapace, Andrea Rossi, Mariantonietta Cicoira, Giorgio Golia, Luisa Zanolla, Lorenzo Franceschini, Luca Conte, Paolo Marino, Piero Zardini, Corrado Vassanelli

    Résumé Résumé Plan Plan  
  • ·Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure

    Page :94-101

    Leong L. Ng, Bhupesh Pathik, Ian W. Loke, Iain B. Squire, Joan E. Davies

    Résumé Résumé Plan Plan  
  • ·Ischemic stroke after heart failure: A community-based study

    Page :102-109

    Brandi J. Witt, Robert D. Brown, Steven J. Jacobsen, Susan A. Weston, Karla V. Ballman, Ryan A. Meverden, Véronique L. Roger

    Résumé Résumé Plan Plan  
  • ·Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non–ST-segment elevation acute coronary syndromes: Results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)

    Page :110-117

    Mauricio G. Cohen, Matthew T. Roe, Jyotsna Mulgund, Eric D. Peterson, Ali F. Sonel, Venu Menon, Sidney C. Smith, Jorge F. Saucedo, Barbara L. Lytle, Charles V. Pollack, Luis Garza, W. Brian Gibler, E. Magnus Ohman

    Résumé Résumé Plan Plan  
  • ·The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction

    Page :118-125

    Peter A. Kavsak, Andrew R. MacRae, Viliam Lustig, Rakesh Bhargava, Rudy Vandersluis, Glenn E. Palomaki, Marie-Jeanne Yerna, Allan S. Jaffe

    Résumé Résumé Plan Plan  
  • ·Recombinant P-selectin glycoprotein ligand–immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial

    Page :125.e1

    Paul Mertens, Alex Maes, Johan Nuyts, Ann Belmans, Walter Desmet, Enric Esplugas, Filip Charlier, Jaime Figueras, Gianmario Sambuceti, Markus Schwaiger, Luc Mortelmans, Frans Van de Werf, for the PSALM investigators h

    Résumé Résumé Plan Plan  
  • ·Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study

    Page :126-135

    Allan S. Jaffe, Harlan M. Krumholz, Diane J. Catellier, Kenneth E. Freedland, Vera Bittner, James A. Blumenthal, James E. Calvin, James Norman, Rafael Sequeira, Christopher O'Connor, Michael W. Rich, David Sheps, Colin Wu, for the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Trial Investigators

    Résumé Résumé Plan Plan
  • ·Estradiol increases platelet aggregation in Pl^A1/A1 individuals

    Page :136-139

    Konstantinos D. Boudoulas, Christine Roos Montague, Pascal J. Goldschmidt-Clermont, Glen E. Cooke

    Résumé Résumé Plan Plan  
  • ·The obesity paradox in non–ST-segment elevation acute coronary syndromes: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative

    Page :140-148

    Deborah B. Diercks, Matthew T. Roe, Jyotsna Mulgund, Charles V. Pollack, J. Douglas Kirk, W. Brian Gibler, E. Magnus Ohman, Sidney C. Smith, William E. Boden, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial

    Page :149-154

    Vivek Rajagopal, A. Michael Lincoff, David J. Cohen, Hitinder S. Gurm, Tingfei Hu, Walter J. Desmet, Neal S. Kleiman, John A. Bittl, Frederick Feit, Eric J. Topol

    Résumé Résumé Plan Plan  
  • ·Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: The Bi vs Left Ventricular Pacing: An International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study

    Page :155.e1

    Maurizio Gasparini, Mario Bocchiardo, Maurizio Lunati, Pier Antonio Ravazzi, Massimo Santini, Marco Zardini, Silvia Signorelli, Micaela Passardi, Catherine Klersy, on behalf of the BELIEVE Investigators

    Résumé Résumé Plan Plan  
  • ·The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion

    Page :155.e9

    Osnat T. Gurevitz, Chitra J. Varadachari, Naser M. Ammash, Joseph F. Malouf, A. Gabriela Rosales, Regina M. Herges, Charles J. Bruce, Virend K. Somers, Stephen C. Hammill, Bernard J. Gersh, Paul A. Friedman

    Résumé Résumé Plan Plan  
  • ·Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements

    Page :156.e1

    Michael Lindstaedt, Aydan Yazar, Alfried Germing, Markus K. Fritz, Tim Holland-Letz, Andreas Mügge, Waldemar Bojara

    Résumé Résumé Plan Plan  
  • ·Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

    Page :157-163

    J. Emilio Exaire, Samuel M. Butman, Ramin Ebrahimi, Neal S. Kleiman, Robert A. Harrington, Marc J. Schweiger, John A. Bittl, Kathy Wolski, Eric J. Topol, A. Michael Lincoff, for the REPLACE-2 Investigators

    Résumé Résumé Plan Plan  
  • ·Borderline left ventricles in prenatally diagnosed atrioventricular septal defect or double outlet right ventricle: Echocardiographic predictors of biventricular repair

    Page :163.e1

    Olli M. Pitkänen, Lisa K. Hornberger, Steven E.S. Miner, Tapas Mondal, Jeffrey F. Smallhorn, Edgar Jaeggi, Lynne E. Nield

    Résumé Résumé Plan Plan  
  • ·Persistence and adherence to cholesterol lowering agents: Evidence from Régie de l'Assurance Maladie du Québec data

    Page :164-169

    Jean Lachaine, Stephane Rinfret, Elizabeth P. Merikle, Jean-Eric Tarride

    Résumé Résumé Plan Plan  
  • ·Conjugated equine estrogens and peripheral arterial disease risk: The Women's Health Initiative

    Page :170-176

    Judith Hsia, Michael H. Criqui, David M. Herrington, JoAnn E. Manson, LieLing Wu, Susan R. Heckbert, Matthew Allison, Mary McGrae McDermott, Jennifer Robinson, Kamal Masaki, for the Women's Health Initiative Research Group

    Résumé Résumé Plan Plan  
  • ·Is alcohol consumption associated with calcified atherosclerotic plaque in the coronary arteries and aorta?

    Page :177-182

    R. Curtis Ellison, Yuqing Zhang, Paul N. Hopkins, Sarah Knox, Luc Djoussé, Jeffrey J. Carr

    Résumé Résumé Plan Plan
  • ·Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

    Page :183-189

    Rajesh Janardhanan, Satish Kenchaiah, Eric J. Velazquez, Yuhyun Park, John J.V. McMurray, W. Douglas Weaver, Peter V. Finn, Harvey D. White, Jose A. Marin-Neto, Chris O'Connor, Marc A. Pfeffer, Robert M. Califf, Scott D. Solomon, for the VALIANT Investigators

    Résumé Résumé Plan Plan  
  • ·Circulating endothelial progenitor cells predict coronary artery disease severity

    Page :190-195

    Geoffrey A. Kunz, Ge Liang, Florim Cuculi, David Gregg, Korkut C. Vata, Linda K. Shaw, Pascal J. Goldschmidt-Clermont, Chunming Dong, Doris A. Taylor, Eric D. Peterson

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Are elevations of N-terminal probrain natriuretic peptide in endurance athletes after prolonged strenuous exercise due to systemic inflammatory cytokines?

    Page :e1

    Craig McLachlan, Peter Mossop

    
  • ·Brain natriuretic peptide (BNP) and exercise-induced immune reactions: Reply to the letter-to-the-editor of McLachlan and Mossop

    Page :e3

    Jurgen W. Scharhag, Wilfried Kindermann

    
  • ·A1c and mortality: An unexpected relationship in patients with advanced heart failure

    Page :e5

    John A. Tayek

    
  • ·Reply

    Page :e7

    Gregg C. Fonarow, Tamara B. Horwich, Shervin Eshaghian

    
  • ·Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure

    Page :e9

    Raquel F. Gerlach, Jose E. Tanus-Santos

    
  • ·What information can an invasive cardiologist obtain from brain natriuretic peptide?

    Page :e11

    Marcin Grabowski, Krzysztof J. Filipiak

    
  • ·Letter to the Editor

    Page :e13

    Reka Faludi, Levente Toth

    
  • ·Response to Letter to the Editor

    Page :e15

    Peter Alter